View in EDS

RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells.

Saved in:
Bibliographic Details
Title: RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells.
Authors: Palassin P; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France., Lapierre M; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France., Bonnet S; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France., Pillaire MJ; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse 31077, France., Győrffy B; Department of Bioinformatics, Semmelweis University and TTK Lendület Cancer Biomarker Research Group, Budapest H-1117, Hungary., Teyssier C; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France., Jalaguier S; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France., Hoffmann JS; Laboratoire de pathologie, Laboratoire d'excellence Toulouse Cancer, Institut Universitaire du Cancer-Toulouse, Oncopole, Toulouse 31059, France., Cavaillès V; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.; Should be considered as co-senior authors., Castet-Nicolas A; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.; Département de Pharmacie Clinique, Centre Hospitalo-Universitaire Montpellier, Montpellier 34295, France.; Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, Montpellier 34090, France.; Should be considered as co-senior authors.
Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2022 May 07; Vol. 5 (2), pp. 401-414. Date of Electronic Publication: 2022 May 07 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35800380
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palassin+P%22">Palassin P</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.<br /><searchLink fieldCode="AU" term="%22Lapierre+M%22">Lapierre M</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.<br /><searchLink fieldCode="AU" term="%22Bonnet+S%22">Bonnet S</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.<br /><searchLink fieldCode="AU" term="%22Pillaire+MJ%22">Pillaire MJ</searchLink>; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.<br /><searchLink fieldCode="AU" term="%22Győrffy+B%22">Győrffy B</searchLink>; Department of Bioinformatics, Semmelweis University and TTK Lendület Cancer Biomarker Research Group, Budapest H-1117, Hungary.<br /><searchLink fieldCode="AU" term="%22Teyssier+C%22">Teyssier C</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.<br /><searchLink fieldCode="AU" term="%22Jalaguier+S%22">Jalaguier S</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.<br /><searchLink fieldCode="AU" term="%22Hoffmann+JS%22">Hoffmann JS</searchLink>; Laboratoire de pathologie, Laboratoire d'excellence Toulouse Cancer, Institut Universitaire du Cancer-Toulouse, Oncopole, Toulouse 31059, France.<br /><searchLink fieldCode="AU" term="%22Cavaillès+V%22">Cavaillès V</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.; Should be considered as co-senior authors.<br /><searchLink fieldCode="AU" term="%22Castet-Nicolas+A%22">Castet-Nicolas A</searchLink>; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier 34298, France.; Département de Pharmacie Clinique, Centre Hospitalo-Universitaire Montpellier, Montpellier 34295, France.; Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, Montpellier 34090, France.; Should be considered as co-senior authors.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101738710%22">Cancer drug resistance (Alhambra, Calif.)</searchLink> [Cancer Drug Resist] 2022 May 07; Vol. 5 (2), pp. 401-414. <i>Date of Electronic Publication: </i>2022 May 07 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22OAE+Publishing+Inc%22">OAE Publishing Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101738710 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2578-532X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222578532X%22">2578532X </searchLink><i>NLM ISO Abbreviation: </i>Cancer Drug Resist <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35800380
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.20517/cdr.2021.133
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 401
    Titles:
      – TitleFull: RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palassin P
      – PersonEntity:
          Name:
            NameFull: Lapierre M
      – PersonEntity:
          Name:
            NameFull: Bonnet S
      – PersonEntity:
          Name:
            NameFull: Pillaire MJ
      – PersonEntity:
          Name:
            NameFull: Győrffy B
      – PersonEntity:
          Name:
            NameFull: Teyssier C
      – PersonEntity:
          Name:
            NameFull: Jalaguier S
      – PersonEntity:
          Name:
            NameFull: Hoffmann JS
      – PersonEntity:
          Name:
            NameFull: Cavaillès V
      – PersonEntity:
          Name:
            NameFull: Castet-Nicolas A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 05
              Text: 2022 May 07
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2578-532X
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer drug resistance (Alhambra, Calif.)
              Type: main
ResultId 1